Dr Akihiko Suto Bedah kanker payudara


Konsultan - kanker payudara bedah , Pangalaman:

buku pasini

Ngeunaan Dokter

Dr Akihiko Suto nyaéta ahli bedah kanker payudara top di Tokyo, Jepang.

Dr Akihiko Suto pakait sareng Rumah Sakit Pusat Kanker Nasional, Jepang.

The Department of Breast Surgery consisting of five staff surgeons specialized in breast cancer (Dr. Kinoshita, Dr. Takayama, Dr. Jimbo, Dr. Shiino, and Dr. Murata), one chief resident (Dr. Watase), and two or three rotating residents, deals with treatment of breast disease through surgeries, as well as diagnosis of breast diseases and assessment of lymph nodes in the axillary and clavicular regions which are suspected harboring metastases. In 2018 fiscal year, we performed a total of 894 operations of breast diseases (770 was primary breast cancer or breast sarkoma). The number of patients we have treated is increasing year by year, and 2018 treated patients number was the highest ever in our department. The trend of surgical procedure also has been changing in recent years. Although breast partial resection (Bp) accounted for 39% of the total surgeries in our department in 2018, and the Bp rate has been constant. On the other hand, immediate reconstruction surgeries have overwhelmingly increased in recent years. A total of 172 immediate breast reconstructions were performed in 2018 fiscal year, comprising 22% of all cases. The rate of mastectomy was 477 cases (60%), including 172 cases of immediate reconstruction. SLNB was performed in 578 (78%) patients, and many patients were spared from ALND in 2018.

rumah sakit

Pusat Kanker Nasional, Jepang

Spésialisasi

  • Bedah kanker payudara

Prosedur Dilaksanakeun

  • Bedah kanker payudara
  • Mastektomi
  • mastectomy parsial
  • Mastektomi radikal

Panilitian & Publikasi

Peryogi bantosan? Tim kami siap ngabantosan anjeun.

Kami ngarepkeun pamulihan gancang tina anu anjeun sayogi sareng anu caket.

×
Mimitian obrolan
Kami Online! Ngobrol Jeung Kami!
Scan kode na
Halo,

Wilujeng sumping di CancerFax!

CancerFax mangrupikeun platform pioneering anu didedikasikeun pikeun ngahubungkeun individu anu nyanghareupan kanker tahap lanjut kalayan terapi sél anu inovatif sapertos terapi CAR T-Cell, terapi TIL, sareng uji klinis di sakuliah dunya.

Hayu urang nyaho naon bisa urang pigawé pikeun anjeun.

1) Pangobatan kanker di luar negeri?
2) Terapi T-Sél mobil
3) Vaksin kanker
4) Konsultasi video online
5) Terapi proton